(BUSINESS WIRE) -- Tecnotree, a global digital platform and services leader for 5G and cloud-native technology, announced its second quarter and half-year results for 2023, demonstrating steady growth in revenue and profitability. The company has shown strong performance with net sales for the review period 10.2% higher as compared to last year, the growth primarily driven by the Middle East Region and North America.

Consolidated highlights of the results of the Second Quarter and Half Year 2023:

Half year (January-June 2023)

Net sales increased 10.2% to EUR 34.8 million

Operating results increased 37.3% to EUR 9.8 million

The net result increased by 11.1% to EUR 5.5 million

Earnings per share were EUR 0.02

Order book at the end of the period stood at EUR 68.4 million

Padma Ravichander, CEO Tecnotree Corporation, said, “As we reach the halfway mark for the year 2023, I am pleased to share Tecnotree’s consist ... Read more »

TOKYO - Friday, 04. August 2023

Safety, Fibrosis control and increased muscle strength reported clinically.

(BUSINESS WIRE) -- Duchenne Muscular Dystrophy (DMD) patients showed signs of disease progress slowing down, after oral consumption of Neu REFIX ß-glucan for 45 days along with routine medications. Clinical improvements published in IBRO Neuroscience reports, might be the world's first such report, wherein, a safe food supplement, mitigated biomarkers of relevance to muscle dysfunction in DMD without side-effects. Increased plasma dystrophin by 32%, indicating improved blood circulation along with muscle strength improvement, is a breakthrough, unraveling the multipronged potential of Neu-REFIX, which also beneficially reconstituted gut microbiome in DMD, gives hope of improving the quality of life and prolonging the life span of DMD patients, opined Dr. Raghavan, the lead author.

Neu-REFIX is an allergen-free ß-glucan, unique for its source, as an ... Read more »